Tanvex Biopharma(TW:6541)
NT$28.15+-0.95 (+1.08%)
TW:6541
Tanvex Biopharma stock forecast
NT$28.15
At close:+-0.95 (+1.08%)
Want to see TW:6541 full AI Analyst Report?
Tanvex Biopharma (6541) Stock Forecast & Price Target
6541 Analyst Ratings
There are no analyst ratings in the last 3 months.
6541 Stock 12 Month Forecast
There are no analyst price targets in the last 3 months.
Detailed List of Analyst Forecasts
Analyst Type
Ranks
Analyst Rating
Upside/ Downside
Action
| Price Target | Article | |||||||
|---|---|---|---|---|---|---|---|---|
| xAI - Grok-4.3 | TipRanks - xAI | TWD 27 | hold | -4.09%Downside | Initiated | 11/10/26 | ||
| PerPlexity - SonarReasoningPro | TipRanks - PerPlexity | TWD 26 | sell | -7.64%Downside | Initiated | 11/10/26 | ||
| DeepSeek - V4Pro | TipRanks - DeepSeek | TWD 28 | hold | -0.53%Downside | Initiated | 11/10/26 | ||
| Google Biotechnology | TipRanks - Google | TWD 26 | sell | -7.64%Downside | Initiated | 11/09/26 | ||
| Anthropic Biotechnology | TipRanks - Anthropic | TWD 26 | sell | -7.64%Downside | Initiated | 11/09/26 | ||
| OpenAI - Gpt-5.6Sol | TipRanks - OpenAI | TWD 27 | hold | -4.09%Downside | Initiated | 11/08/26 |
| Rating | Article | ||||
|---|---|---|---|---|---|
| xAI - Grok-4.3TipRanks - xAI | HoldInitiatedTWD 27 | 11/10/26 | -4.09%Downside | ||
| PerPlexity - SonarReasoningProTipRanks - PerPlexity | SellInitiatedTWD 26 | 11/10/26 | -7.64%Downside | ||
| DeepSeek - V4ProTipRanks - DeepSeek | HoldInitiatedTWD 28 | 11/10/26 | -0.53%Downside | ||
| Google BiotechnologyTipRanks - Google | SellInitiatedTWD 26 | 11/09/26 | -7.64%Downside | ||
| Anthropic BiotechnologyTipRanks - Anthropic | SellInitiatedTWD 26 | 11/09/26 | -7.64%Downside | ||
| OpenAI - Gpt-5.6SolTipRanks - OpenAI | HoldInitiatedTWD 27 | 11/08/26 | -4.09%Downside |
Stocks with the Highest Top Analyst Consensus in the General Sector
6541 Analyst Recommendation Trends
| Rating | Jun 26 | Jul 26 | Aug 26 | Sep 26 | Oct 26 |
|---|---|---|---|---|---|
| Strong Buy | 0 | 0 | 0 | 0 | 0 |
| Buy | 0 | 0 | 0 | 0 | 0 |
| Hold | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 |
| total | 0 | 0 | 0 | 0 | 0 |
In the current month, 6541 has received 0 Buy Ratings, 0 Hold Ratings, and 0 Sell Ratings. 6541 average Analyst price target in the past 3 months is ―.
6541 Financial Forecast
ConsensusTWD -1.51
6541 Earnings Forecast
Next quarter’s earnings estimate for 6541 is -TWD 1.51 with a range of ― to ―. The previous quarter’s EPS was -TWD 1.51. Its overall industry beat the EPS estimate 50.49% of the time in the past 12 months.
ConsensusTWD 159M
6541 Sales Forecast
Next quarter’s sales forecast for 6541 is TWD 158.84M with a range of ― to ―. The previous quarter’s sales results were TWD 158.84M. Its overall industry beat sales estimates 63.25% of the time in the past 12 months.
6541 Stock Forecast FAQ
Can I see which stocks the top-ranking analysts are rating?
Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
How can I follow the stock ratings of top Wall Street analysts?
Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
What do analysts say about Tanvex Biopharma?
Not enough analysts have published a price target to provide an average price target.
How can I buy shares of Tanvex Biopharma?
To buy shares of TW:6541, you can open a brokerage account. See exclusive account opening deals on our Best Online Brokers page.
